However, as the clinical significant correlation between blood NF-H levels and functional outcome does not appear until 1 week after symptom onset, NF-H appears not to be a good biomarker in the acute setting and therefore not a good biomarker to discern between TIA and ischemic stroke. This evidence concerns the gene NEFH and transient ischemic attack.